Search Results
Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Christina Antza in
Google Scholar
PubMed
Search for other papers by Georgios Kostopoulos in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Samiul Mostafa in
Google Scholar
PubMed
Centre of Endocrinology Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Search for other papers by Krishnarajah Nirantharakumar in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Centre of Endocrinology Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Search for other papers by Abd Tahrani in
Google Scholar
PubMed
infraction, cerebral infraction, diabetes), (13) total calorie intake, (14) depression and other mental disorders, (15) sleep-related disorders (insomnia, snoring), (16) use of hypnotic drugs, (17) postmenopausal hormone medications, (18) family history of
Search for other papers by Nicole G Barra in
Google Scholar
PubMed
Search for other papers by Fernando F Anhê in
Google Scholar
PubMed
Search for other papers by Joseph F Cavallari in
Google Scholar
PubMed
Search for other papers by Anita M Singh in
Google Scholar
PubMed
Search for other papers by Darryl Y Chan in
Google Scholar
PubMed
Search for other papers by Jonathan D Schertzer in
Google Scholar
PubMed
excess status linked to T2DM Supplementation: ↓BW, adiposity, liver weight ↑blood thyroid hormone (TSH, TT3, FT3, FT4) High I dose: Pancreatic destruction, hyperglycemia Impair beta cell insulin secretion, apoptosis Selenium (Se) Male: 55 µg
Search for other papers by Andre Sarmento-Cabral in
Google Scholar
PubMed
Search for other papers by Mercedes del Rio-Moreno in
Google Scholar
PubMed
Search for other papers by Mari C Vazquez-Borrego in
Google Scholar
PubMed
Search for other papers by Mariyah Mahmood in
Google Scholar
PubMed
Search for other papers by Elena Gutierrez-Casado in
Google Scholar
PubMed
Search for other papers by Natalie Pelke in
Google Scholar
PubMed
Search for other papers by Grace Guzman in
Google Scholar
PubMed
Search for other papers by Papasani V Subbaiah in
Google Scholar
PubMed
Search for other papers by Jose Cordoba-Chacon in
Google Scholar
PubMed
Search for other papers by Shoshana Yakar in
Google Scholar
PubMed
Search for other papers by Rhonda D Kineman in
Google Scholar
PubMed
Introduction In the healthy liver, hepatocyte growth hormone receptor (GHR)-signaling activates multiple intracellular signal transduction pathways to modulate hepatic function ( Dehkhoda et al. 2018 ). It is well accepted that GH signals
Search for other papers by Yanli Miao in
Google Scholar
PubMed
Search for other papers by Haojie Qin in
Google Scholar
PubMed
Search for other papers by Yi Zhong in
Google Scholar
PubMed
Search for other papers by Kai Huang in
Google Scholar
PubMed
Search for other papers by Caijun Rao in
Google Scholar
PubMed
orexigenic hormone that increases appetite and ultimately leads to obesity and weight gain ( Duerrschmid et al. 2017 ). However, its metabolic regulation on adipose tissue itself has not been studied. Our findings indicated that the expression of asprosin
Search for other papers by Marion Régnier in
Google Scholar
PubMed
Search for other papers by Matthias Van Hul in
Google Scholar
PubMed
European Associated Laboratory (EAL) ‘NeuroMicrobiota’, Brussels/Toulouse, Belgium
Search for other papers by Claude Knauf in
Google Scholar
PubMed
European Associated Laboratory (EAL) ‘NeuroMicrobiota’, Brussels/Toulouse, Belgium
Search for other papers by Patrice D Cani in
Google Scholar
PubMed
intestinal homeostasis (gut microbiota composition and gut barrier function) directly or indirectly (via microbial-produced metabolites) disturbs the production and secretion of gut endocrine hormones, thereby triggering metabolic diseases ( Fig. 2 ). The
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Search for other papers by Lei Du in
Google Scholar
PubMed
Search for other papers by Yang Wang in
Google Scholar
PubMed
Search for other papers by Cong-Rong Li in
Google Scholar
PubMed
Search for other papers by Liang-Jian Chen in
Google Scholar
PubMed
Search for other papers by Jin-Yang Cai in
Google Scholar
PubMed
Search for other papers by Zheng-Rong Xia in
Google Scholar
PubMed
Search for other papers by Wen-Tao Zeng in
Google Scholar
PubMed
Search for other papers by Zi-Bin Wang in
Google Scholar
PubMed
Search for other papers by Xi-Chen Chen in
Google Scholar
PubMed
Search for other papers by Fan Hu in
Google Scholar
PubMed
Animal Core Facility, Nanjing Medical University, Nanjing, Jiangsu, China
Search for other papers by Dong Zhang in
Google Scholar
PubMed
Search for other papers by Xiao-Wei Xing in
Google Scholar
PubMed
Search for other papers by Zhi-Xia Yang in
Google Scholar
PubMed
Introduction As a core reproductive organ, the ovary has two unique functions: producing mature oocytes for fertilization and secreting sex hormones for maintaining the normal activities of multiple organs, including itself. The normal
Search for other papers by Wenjuan Liu in
Google Scholar
PubMed
Search for other papers by Harry Kevin Lau in
Google Scholar
PubMed
Search for other papers by Dong Ok Son in
Google Scholar
PubMed
Division of Advanced Diagnostics, Toronto General Research Institutes, University Health Network, Toronto, Ontario, Canada
Banting and Best Diabetes Centre, University of Toronto, Toronto, Ontario, Canada
Search for other papers by Tianru Jin in
Google Scholar
PubMed
Search for other papers by Yehong Yang in
Google Scholar
PubMed
Search for other papers by Zhaoyun Zhang in
Google Scholar
PubMed
Search for other papers by Yiming Li in
Google Scholar
PubMed
Search for other papers by Gerald J Prud’homme in
Google Scholar
PubMed
Search for other papers by Qinghua Wang in
Google Scholar
PubMed
the β-cell mass and provide improved treatments for T1D and T2D subjects. Glucagon-like peptide-1 (GLP-1) is an incretin hormone released from gastrointestinal L cells in response to food ingestion, and has been currently used for the treatment of T2
Search for other papers by Robin Kristófi in
Google Scholar
PubMed
Search for other papers by Jan W Eriksson in
Google Scholar
PubMed
levels of inflammatory cytokines such as tumor necrosis factor alpha (TNF-α), IL-6 and C-reactive protein (CRP). In addition, levels of the anti-inflammatory adipocyte-derived hormone adiponectin increased and signs of endothelial dysfunction improved
Search for other papers by Sarah J Richardson in
Google Scholar
PubMed
Search for other papers by Alberto Pugliese in
Google Scholar
PubMed
, and evidence of impaired proinsulin hormone processing within the remaining beta cells. In these patients, proinsulin is found in mature granules, colocalizing with the processed insulin. Similar observations in terms of proinsulin were made in the